$PRTA
PROTHENA CORP PUBLIC LTD CO Stock $prta

$prta Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000155905315000023 Filed on May 06, 2015

Income Statement

Concept	2015 Q1	2014 Q1
Revenue	$593.0K	$32.23M
YoY Change	-98.16%	18750.29%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.050M	$4.870M
YoY Change	3.7%	53.14%
% of Gross Profit
Research & Development	$10.57M	$9.342M
YoY Change	13.18%	56.82%
% of Gross Profit
Depreciation & Amortization	$193.0K	$175.0K
YoY Change	10.29%	27.74%
% of Gross Profit
Operating Expenses	$15.62M	$14.22M
YoY Change	9.9%	55.56%
Operating Profit	-$15.03M	$18.02M
YoY Change	-183.41%	-300.95%
Interest Expense	$30.00K	$20.00K
YoY Change	50.0%	0.0%
% of Operating Profit		0.11%
Other Income/Expense, Net	$93.00K	-$16.00K
YoY Change	-681.25%	-172.73%
Pretax Income	-$14.94M	$18.00M
YoY Change	-182.96%	-301.26%
Income Tax	$266.0K	$151.0K
% Of Pretax Income		0.84%
Net Earnings	-$15.20M	$17.85M
YoY Change	-185.16%	-299.44%
Net Earnings / Revenue	-2563.58%	55.38%
Basic Earnings Per Share	-$0.55	$0.82
Diluted Earnings Per Share	-$0.55	$0.78
COMMON SHARES
Basic Shares Outstanding	27.40M shares	21.88M shares
Diluted Shares Outstanding	27.40M shares	22.94M shares

Balance Sheet

Concept	2015 Q1	2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$279.9M	$195.1M
YoY Change	43.46%	63.13%
Cash & Equivalents	$279.9M	$195.1M
Short-Term Investments
Other Short-Term Assets	$3.200M	$2.400M
YoY Change	33.33%	140.0%
Inventory
Prepaid Expenses
Receivables	$1.357M	$2.161M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$284.4M	$199.6M
YoY Change	42.5%	65.24%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.956M	$3.233M
YoY Change	-8.57%	-4.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$117.0K	$1.000M
YoY Change	-88.3%	900.0%
Total Long-Term Assets	$5.166M	$4.212M
YoY Change	22.65%	21.14%
TOTAL ASSETS
Total Short-Term Assets	$284.4M	$199.6M
Total Long-Term Assets	$5.166M	$4.212M
Total Assets	$289.6M	$203.8M
YoY Change	42.09%	64.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.990M	$2.128M
YoY Change	-6.48%
Accrued Expenses	$6.400M	$5.700M
YoY Change	12.28%	67.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$9.544M	$8.964M
YoY Change	6.47%	76.25%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$126.0K	$1.800M
YoY Change	-93.0%	28.57%
Total Long-Term Liabilities	$2.615M	$1.800M
YoY Change	45.28%	28.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$9.544M	$8.964M
Total Long-Term Liabilities	$2.615M	$1.800M
Total Liabilities	$12.16M	$10.80M
YoY Change	12.59%	66.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$63.69M	-$23.49M
YoY Change	171.16%	152.68%
Common Stock	$275.0K	$219.0K
YoY Change	25.57%	23.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$277.4M	$193.0M
YoY Change
Total Liabilities & Shareholders Equity	$289.6M	$203.8M
YoY Change	42.09%	64.01%

Cashflow Statement

Concept	2015 Q1	2014 Q1
OPERATING ACTIVITIES
Net Income	-$15.20M	$17.85M
YoY Change	-185.16%	-299.44%
Depreciation, Depletion And Amortization	$193.0K	$175.0K
YoY Change	10.29%	27.74%
Cash From Operating Activities	-$14.72M	$17.89M
YoY Change	-182.26%	-450.66%
INVESTING ACTIVITIES
Capital Expenditures	-$30.00K	-$30.00K
YoY Change	0.0%	-127.27%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$28.00K	-$26.00K
YoY Change	7.69%	-76.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.026M	$507.0K
YoY Change	102.37%	-703.57%
NET CHANGE
Cash From Operating Activities	-$14.72M	$17.89M
Cash From Investing Activities	-$28.00K	-$26.00K
Cash From Financing Activities	$1.026M	$507.0K
Net Change In Cash	-$13.72M	$18.38M
YoY Change	-174.68%	-446.89%
FREE CASH FLOW
Cash From Operating Activities	-$14.72M	$17.89M
Capital Expenditures	-$30.00K	-$30.00K
Free Cash Flow	-$14.69M	$17.92M
YoY Change	-181.96%	-443.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001559053
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	31285885	shares
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	Prothena Corp plc
CY2015Q1	dei	Trading Symbol TradingSymbol	PRTA
CY2014Q1	prta	Accrued Offering Costs AccruedOfferingCosts	43000	USD
CY2015Q1	prta	Accrued Offering Costs AccruedOfferingCosts	117000	USD
CY2014Q4	prta	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	2285000	USD
CY2015Q1	prta	Accrued Research And Development Current AccruedResearchAndDevelopmentCurrent	3662000	USD
CY2014Q1	prta	Collaboration Revenue CollaborationRevenue	32096000	USD
CY2015Q1	prta	Collaboration Revenue CollaborationRevenue	593000	USD
CY2014Q4	prta	Deferred Shares Par Value DeferredSharesParValue	22
CY2015Q1	prta	Deferred Shares Par Value DeferredSharesParValue	22
CY2014Q4	prta	Deferred Shares Share Issued DeferredSharesShareIssued	0	shares
CY2015Q1	prta	Deferred Shares Share Issued DeferredSharesShareIssued	0	shares
CY2014Q4	prta	Deferred Shares Share Outstanding DeferredSharesShareOutstanding	0	shares
CY2015Q1	prta	Numberof Votes NumberofVotes	1	vote
CY2014Q1	prta	Receivable Stock Option Exercises ReceivableStockOptionExercises	0	USD
CY2015Q1	prta	Deferred Shares Share Outstanding DeferredSharesShareOutstanding	0	shares
CY2014Q4	prta	Deferred Shares Shares Authorized DeferredSharesSharesAuthorized	10000	shares
CY2015Q1	prta	Deferred Shares Shares Authorized DeferredSharesSharesAuthorized	10000	shares
CY2014Q4	prta	Deferred Shares Value DeferredSharesValue	0	USD
CY2015Q1	prta	Deferred Shares Value DeferredSharesValue	0	USD
CY2015Q1	prta	Gain Losson Sublease GainLossonSublease	-400000	USD
CY2014Q1	prta	Gain Losson Sublease Noncash Portion GainLossonSubleaseNoncashPortion	0	USD
CY2015Q1	prta	Gain Losson Sublease Noncash Portion GainLossonSubleaseNoncashPortion	-261000	USD
CY2015Q1	prta	Receivable Stock Option Exercises ReceivableStockOptionExercises	16000	USD
CY2015Q1	prta	Sublease Leases Optional Extension Term SubleaseLeasesOptionalExtensionTerm	P1Y
CY2015Q1	prta	Sublease Leases Term SubleaseLeasesTerm	P3Y
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4722000	USD
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1990000	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1729000	USD
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1357000	USD
CY2014Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	57000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2014Q4	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	98000	USD
CY2015Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	98000	USD
CY2014Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1169000	USD
CY2015Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	390000	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4711000	USD
CY2015Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4904000	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	338106000	USD
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	340844000	USD
CY2014Q4	us-gaap	Assets Assets	304116000	USD
CY2015Q1	us-gaap	Assets Assets	289585000	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	299275000	USD
CY2015Q1	us-gaap	Assets Current AssetsCurrent	284419000	USD
CY2014Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	4841000	USD
CY2015Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	5166000	USD
CY2014Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	137000	USD
CY2015Q1	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	138000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	176677000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	195052000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293579000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	279857000	USD
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	18375000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-13722000	USD
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27466407	shares
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27388005	shares
CY2014Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2090000	USD
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27388005	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27466407	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	274000	USD
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	275000	USD
CY2014Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-159000	USD
CY2015Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-369000	USD
CY2014Q4	us-gaap	Deferred Rent Credit DeferredRentCredit	172000	USD
CY2015Q1	us-gaap	Deferred Rent Credit DeferredRentCredit	181000	USD
CY2015Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	2391000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	167000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	163000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	1720000	USD
CY2015Q1	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	2093000	USD
CY2014Q1	us-gaap	Depreciation Depreciation	200000	USD
CY2015Q1	us-gaap	Depreciation Depreciation	200000	USD
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	175000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	193000	USD
CY2014Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	30000	USD
CY2015Q1	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	30000	USD
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.82
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.55
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.78
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.55
CY2014Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3138000	USD
CY2015Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	2784000	USD
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	207000	USD
CY2015Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	390000	USD
CY2014Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	207000	USD
CY2015Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	390000	USD
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4873000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5049000	USD
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18003000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-14936000	USD
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	151000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	266000	USD
CY2014Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	436000	USD
CY2015Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	442000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1746000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2221000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2161000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-372000	USD
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-12000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	0	USD
CY2014Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	707000	USD
CY2015Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-933000	USD
CY2014Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	19000	USD
CY2015Q1	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	26000	USD
CY2014Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2214000	USD
CY2015Q1	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	2217000	USD
CY2014Q4	us-gaap	Liabilities Liabilities	14227000	USD
CY2015Q1	us-gaap	Liabilities Liabilities	12159000	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	304116000	USD
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	289585000	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12039000	USD
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	9544000	USD
CY2014Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2188000	USD
CY2015Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2615000	USD
CY2014Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5481000	USD
CY2015Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	5505000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	507000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1026000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28000	USD
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17894000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14720000	USD
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	17852000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-15202000	USD
CY2014Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	10000	USD
CY2015Q1	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	93000	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	14215000	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	15622000	USD
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	18019000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-15029000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2015Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	117000	USD
CY2014Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4975000	USD
CY2015Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3892000	USD
CY2014Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	0	USD
CY2015Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	126000	USD
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-35000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	67000	USD
CY2014Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	496000	USD
CY2015Q1	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	537000	USD
CY2014Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	10000	USD
CY2015Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2014Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	26000	USD
CY2015Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	28000	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3770000	USD
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3012000	USD
CY2014Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	310000	USD
CY2015Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	636000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7832000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7860000	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3121000	USD
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2956000	USD
CY2015Q1	us-gaap	Purchase Obligation PurchaseObligation	1200000	USD
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9342000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10573000	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-48491000	USD
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-63693000	USD
CY2014Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	138000	USD
CY2015Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	0	USD
CY2014Q1	us-gaap	Revenues Revenues	32234000	USD
CY2015Q1	us-gaap	Revenues Revenues	593000	USD
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1343000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1703000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	289889000	USD
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	277426000	USD
CY2014Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1058000	shares
CY2015Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22942000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27401000	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21884000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27401000	shares
CY2015Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Condensed Consolidated Financial Statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures. On an ongoing basis, management evaluates its estimates, including critical accounting policies or estimates related to revenue recognition, share-based compensation and research and development expenses. The Company bases its estimates on historical experience and on various other market specific and other relevant assumptions that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Because of the uncertainties inherent in such estimates, actual results may differ materially from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001559053-15-000023-index-headers.html	Edgar Link	pending
0001559053-15-000023-index.html	Edgar Link	pending
0001559053-15-000023.txt	Edgar Link	pending
0001559053-15-000023-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
prta-20150331.xml	Edgar Link	completed
prta-20150331.xsd	Edgar Link	pending
prta-20150331_cal.xml	Edgar Link	unprocessable
prta-20150331_def.xml	Edgar Link	unprocessable
prta-20150331_lab.xml	Edgar Link	unprocessable
prta-20150331_pre.xml	Edgar Link	unprocessable
prta2015q110-q.htm	Edgar Link	pending
prta2015q110-qxex311.htm	Edgar Link	pending
prta2015q110-qxex312.htm	Edgar Link	pending
prta2015q110-qxex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PRTA
PROTHENA CORP PUBLIC LTD CO Stock $prta

2015 Q1 Form 10-Q Financial Statement

#000155905315000023 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRTA PROTHENA CORP PUBLIC LTD CO Stock $prta

2015 Q1 Form 10-Q Financial Statement

#000155905315000023 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PRTA
PROTHENA CORP PUBLIC LTD CO Stock $prta